Association of Pioglitazone with Increased Risk of Prostate Cancer and Pancreatic Cancer: A Functional Network Study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of Pioglitazone with Increased Risk of Prostate Cancer and Pancreatic Cancer: A Functional Network Study
Authors
Keywords
-
Journal
Diabetes Therapy
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-25
DOI
10.1007/s13300-018-0509-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPARγ-independent pathway
- (2017) Masanobu Tsubaki et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Inhibition of NF-κB prevents the acidic bile-induced oncogenic mRNA phenotype, in human hypopharyngeal cells
- (2017) Dimitra P. Vageli et al. Oncotarget
- Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes
- (2017) Hua Qu et al. Scientific Reports
- Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
- (2017) Elena Filipova et al. Diabetes Therapy
- Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
- (2017) Elena Filipova et al. Diabetes Therapy
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes
- (2015) James D. Lewis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer
- (2015) Zoran Culig JOURNAL OF CELLULAR PHYSIOLOGY
- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
- (2015) Agnieszka K. Witkiewicz et al. Nature Communications
- Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors
- (2014) David Della-Morte et al. PHARMACOGENOMICS
- Can genome engineering be used to target cancer-associated enhancers?
- (2014) Matthew R Grimmer et al. Epigenomics
- Observational follow-up of the PROactive study: a 6-year update
- (2013) E. Erdmann et al. DIABETES OBESITY & METABOLISM
- Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies
- (2013) M. Ferwana et al. DIABETIC MEDICINE
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Outcomes and lessons from the PROactive study
- (2012) André J. Scheen DIABETES RESEARCH AND CLINICAL PRACTICE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARα+γAgonists
- (2009) Martin B. Oleksiewicz et al. PPAR Research
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started